1. A very low dose intravenous dexamethasone suppression test as an index of glucocorticoid sensitivity.
- Author
-
Faria CD, Cobra JF, Sousa E Silva T, Melo MR, Rocha MN, Hayashi LS, Faria TG, de Souza e Almeida JA, Kater CE, and Longui CA
- Subjects
- Adolescent, Adult, Child, Female, Humans, Male, Middle Aged, Pilot Projects, Dexamethasone administration & dosage, Hydrocortisone blood, Receptors, Glucocorticoid drug effects
- Abstract
Background/aims: The wide variability of responses to corticotherapy suggests a role for individual recognition of steroid sensitivity in order to customize treatment. Oral dexamethasone (DEX) administration may be hindered by the rate of its intestinal absorption and the liver first-passage effect. In this study we suggest that an intravenous very low dose DEX suppression test (VLD IV-DST) can be used as an index for glucocorticoid (GC) sensitivity., Methods: We evaluated 87 normal subjects: 44 prepubertal children, 23 adolescents and 20 adults with a VLD IV-DST using 20 mug/m(2) of DEX (dose able to recognize GC sensitivity). Cortisol was initially measured at several time-points after DEX prompting us to establish its nadir and subsequent simplification of the test by measuring cortisol at baseline and after 120 min., Results: Baseline cortisol was similar in adolescents and in adults, but lower in children. There was a spectrum of individual responses in all age groups. The percent reduction of cortisol after 120 min was different in these three age groups, with median values of 44.4% in children, 25.9% in adolescents and 61.6% in adults., Conclusion: This simplified VLD IV-DST using 20 mug/m(2) of DEX is useful to evaluate individual sensitivity to GC in different age groups., ((c) 2008 S. Karger AG, Basel)
- Published
- 2008
- Full Text
- View/download PDF